Activities of RXRa and AHR were also decreased; RXRa represses liver fibrosis by blocking hepatic stellate cell activation and proliferation,[40] while AHR modulates inflammasome activation through inhibition of NF‐kB.[41]. Here, NFKB1 is linked to Hepatic fibrosis.